Synergistic action of ampicillin and nafcillin against ampicillin-resistant Haemophilus influenzae.

Antimicrobial Agents and Chemotherapy
R YogevA T Davis

Abstract

Six strains of ampicillin-resistant Haemophilus influenzae type b were studied in vitro for synergy between ampicillin and nafcillin. The minimal inhibitory concentrations for these strains with 10(4) colony-forming units per ml were 6.25 to 12.5 microgram of ampicillin per ml and 6.25 to 25 microgram of nafcillin per ml. Studies with these agents demonstrated synergism against all six strains of H. influenzae type b. Most strains were inhibited by 0.78 microgram of nafcillin plus 0.78 microgram of ampicillin per ml. A child with osteomyelitis caused by H. influenzae type b was successfully treated with a combination of ampicillin and nafcillin. These data suggest that further studies assessing the synergistic effect of this drug combination against H. influenzae type b are warranted.

References

Mar 27, 1976·Lancet·A MantenM Dessens-Kroon
Mar 18, 1978·British Medical Journal·A L KinmonthR G Mitchell
Dec 1, 1978·The Journal of Pediatrics·W E FeldmanL R Stanberry
Feb 23, 1974·Lancet·W J ThomasD W Bailey
Jul 15, 1974·JAMA : the Journal of the American Medical Association·W KhanA K Saz
Nov 1, 1974·Antimicrobial Agents and Chemotherapy·W E Farrar, N M O'Dell

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.